Catalyst Wire Dossier Catalyst Wire Dossier

SEMICAL GEL-B CROSS Therapy

SEMICAL GEL-B CROSS · Semikal Technology
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SEMICAL GEL-B CROSS Therapy, covering 2025-08-21 to 2025-08-21. Get the full timeline:

Most recent: Clinical Trial Update: Effectiveness and Safety of Intra-articular SEMICAL GEL-B CROSS Therapy in Knee Osteoarthritis (SEM-ART1) [NA]

See pricing